| Dr Patricia Neely Wold, MD | |
|
355 Thayer St, Providence, RI 02906-1550 | |
| (401) 331-4569 | |
| Not Available |
| Full Name | Dr Patricia Neely Wold |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 355 Thayer St, Providence, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215944830 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 3655 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Patricia Neely Wold, MD 1520 High Hawk Rd, E Greenwich, RI 02818-1317 Ph: (401) 885-0258 | Dr Patricia Neely Wold, MD 355 Thayer St, Providence, RI 02906-1550 Ph: (401) 331-4569 |
News Archive
Researchers revealed that Atg13 links autophagy initiation factors to each other using a string-like conformation, thereby promoting the association of diverse elements of the autophagy initiation machinery, initiating autophagosome formation through the recruitment of Atg9 vesicles and phosphorylation of various Atg factors.
A southern Taiwan-based National Cheng Kung University (NCKU) research team has discovered that rapamycin, a drug as a autophagy activator is a possible treatment to alleviating frontotemporal lobar degeneration (FTLD), one of the mainly causes of dementia, and so far no medication can be used.
pSivida Corp., a leader in the development of back of the eye drug delivery systems, today announced that two poster presentations will be made at the upcoming ARVO meeting on one of pSivida's next generation bioerodible technologies for degenerative eye disease. It marks a key step toward the ability to use pSivida's bioerodible technologies to develop treatments for glaucoma and other degenerative eye diseases, diseases that affect millions of Americans.
A multinational clinical trial led by UT Southwestern Medical Center and others found that injection of a new long-acting insulin combined with another drug improves glucose control in patients with Type 2 diabetes and, additionally, is associated with weight loss.
A Columbia University Medical Center research team has uncovered how stimulation of a particular brain region can help stave off the deficits in working memory, associated with an extended sleep deprivation.
› Verified 1 days ago
Dr. Dana Siperstein, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 167 Point St, Providence, RI 02903 Phone: 401-793-8808 Fax: 401-793-8851 | |
Giuseppe Salvatore D'amelio Iv, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 167 Point St, Providence, RI 02903 Phone: 401-793-8808 | |
Eugenie Atallah, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-606-2645 Fax: 401-606-4386 | |
Dr. Luisa Skoble, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5448 Fax: 401-444-6119 | |
Arnaldo A Berges, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Jane Brown 5s, Providence, RI 02903 Phone: 401-444-5448 Fax: 401-444-6119 | |
Sharath Ponnappa Puttichanda, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 345 Blackstone Blvd, Providence, RI 02906 Phone: 401-455-6346 Fax: 401-455-6532 | |
Loreen Phyllis Carol Pirnie, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5448 |